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Immunoperoxidase lectrophoresis, combining SDS-ME-PAGE and the ‘double bridge’ 
immunoperoxidase staining was pplied to crude human pituitary homogenates. With anti-hGH and anti- 
hPL sera, 4 hGH-related monomers were characterized: a I%& 22000 peptide corresponding to hGH; a M, 
20000 peptide corresponding to the known hGH variant and two unknown hGH variants (&Jr 65 000 and 
M, 75 000). With anti-ovine, rat and human PRL sera, 4 PRL-related monomers were immunostained: one 
comigrated with purified hPRL (MI 25 000), and 3 were unknown (Mr 29000; M, 45 000; A4, 16000). 
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1. INTRODUCTION 
Immunocytochemistry (ICC) is such a sensitive 
immunological method that the use of the double- 
bridge immunoperoxidase technique [I] is con- 
sidered to allow the detection of < 1 pg of a given 
protein/cell. Thus, ICC procedures are widely 
used to screen the cellular localization of numerous 
peptidic hormones. Unfortunately, specific ICC 
staining with an ~ti-hormone serum demonstrates 
neither the homogeneity of the protein detected 
nor its identity with the purified protein used as 
immunogen. Methodological artefacts or cross- 
reactions of specific antisera with unrelated pep- 
tides are of further concern when unanticipated 
ICC staining is observed in a given tissue [2]. 
Abbreviations: GH, growth hormone; h, human; hPL, 
human placental lactogen; ICC, immunocytochemistry; 
IPE, immunoperoxidase electrophoresis; ME, 
2-mercapthoethanol; NRS, normal rabbit serum; NSS, 
normal sheep serum; NTC, nitrocellulose; PAGE, 
polyacry~~ide gel eIectrophoresis; PRL, prolactin; sA- 
rGG, sheep anti-rabbit gamma globulin; SDS, sodium 
dodecyl sulfate 
To obviate such pitfalls and to make full use of 
the sensitivity of ICC in the physico-chemical 
characterization of immunoreactive peptidic hor- 
mone variants, we developed a new analytical 
technique combining the high separating power of 
SDS-polyacrylamide gel electrophoresis in the 
presence of ME [3] and the extreme sensitivity of 
the double-bridge immunoperoxidase staining [I]. 
This technique, we call ‘immunoperoxidase- 
electrophoresis’ (IPE), can be directly applied to 
whole tissue homogenates. Here, IPE was applied 
to the human pituitary to separate and characterize 
the molecular forms of hGH and hPRL. This 
gland is known to contain mg amounts of hGH 
and onlybg amounts of hRPL [4]. In [5], 15% of 
the hGH content of the pituitary was shown to 
consist of a lower-&& variant, characterized by a 15 
amino acid deletion (between positions 32 and 46). 
No such heterogeneity of monomeric forms has 
been reported so far for hPRL. 
2. MATERIALS AND METHODS 
Three normal human pituitaries from elderly pa- 
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tients (1 Q ,2op) were removed at autopsy in < 6 h 
after death. The posterior lobe was discarded and 
the anterior lobe stored in liquid nitrogen until use. 
Thawed tissue (50 mg) were homogenized in 1 ml 
SDS-ME buffer I125 mM Tris-HCl (PH 6.8) con- 
taining 1% SDS, 1% ME, 20% sucrose, and 
0.01% phenol red as tracking dye]. The 
homogenate was sonicated at 120 W for 1 min, 
boiled for 1 min, and centrifuged at 50000 x g for 
20 min. The supematant was adequately diluted in 
SDS-ME buffer and lo/t1 aliquots were applied to 
the top of a 80 x 80 x 0.7 mm polyacrylamide gel 
as in [3], with 5% acrylamide for the stacking gel 
and 14% acrylamide for the separating gel. 
SDS-PAGE in the GE 214 apparatus from Phar- 
macia (Uppsala) was run at 60 V during sample 
migration in the stacking gel, then continued at 120 
V until the tracking dye had reached the bottom of 
the gel. Purified hPRL (NIAMDD I-6, 
AFP-2284C2, NIH) diluted at 5 pg/ml SDS-ME 
buffer, and boiled for 1 min before SDS-PAGE 
served as a reference. 
The electrophoretic transfer of proteins from the 
gel to nitrocellulose (NTC) was achieved by insert- 
ing the gel between two sheets of NTC paper (Sar- 
torius GmbH, Gottingen) as in [6] and applying a 
transverse lectrical field of 30 V for 120 min. The 
electrode buffer was made of 25 mM Tris, 192 mM 
glycine, and 20% (v/v) methanol @H 8.3). Under 
these conditions,. a standard of “‘1-hPRL was 
transferred from the gel onto the cathodic NTC 
sheet with a yield >70%. The proteins were fixed 
in 5% sulfosalicylic acid, 10% trichloroacetic acid 
for 30 min and the cathodic NTC sheet was then 
washed in water. Untransferred proteins remaining 
on the gel were stained by silver [7]. 
Washed cathodic NTC sheets were handled by a 
modified double-bridge immunopero~dase techni- 
que used as for -immunoc~ochemist~ [ 1, 81. After 
immersion for 10 min in 2% (v/v) normal sheep 
serum (NSS), NTC sheets were incubated for 48 h 
at 4OC in the presence of one of the following 
specific rabbit anti-hormone sera: anti-hPRL 
(AFP-1, NIH), anti-oPRL (Ba-603) 191, anti-oPRL 
(Ni-770) [lo], anti-rPRL (Re-3) Ill], anti-hGH 
(Ra-2) [ 121, and anti-hPL (Du-2) [13]. Each serum 
was diluted 1: 1000 or more in PBS-NSS buffer 
made of 10 mM sodium phosphate (pH 7.4) con- 
taining 145 mM NaCl, Ic’lo (v/v) normal sheep 
serum, and 0.1% NaN3. As controls 1141, NTC 
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sheets were incubated with PBS-NSS buffer alone 
or with non-immune rabbit serum (NRS) diluted as 
the antisera. The anti-hormone antibodies, attach- 
ed to the immunoreactive sites in NTC sheets were 
then exposed for 10 min to sheep anti-rabbit IgG 
serum (sA-rGG) [9] diluted 1: 100 in PBS-NSS. 
The remaining free valences of this antiserum were 
next allowed to bind for 10 min to the Fc portion 
of horseradish peroxidase-rabbit antiperoxidase 
IgG complexes (PAP Dako Immuno~obulins, 
Denmark) diluted 1: 100 in PBS-NSS. This two- 
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Fig. 1. IPE pattern of a crude human pituitary 
homogenate (lanes a,b; 50 pg tissue wet wt in 10 pl 
SDS-ME buffer) and of purified human prolactin (lanes 
c,d; 50 ng in 10 pi SDS-ME buffer) with anti-hGH 
(lanes a,d) and auti-oPRL (lanes b,c) sera. The two 
antisera were diluted 1: 10000. The mobilities and 
corresponding iU, (x lo-‘) of proteins of the low-N. 
(LMW) SDS calibration kit are indicated by the arrow:, 
on the left. The M, (x 10m3) corresponding to the 
protein bands immunostained with anti-hGH and anti- 
oPRL sera are indicated on the right. 
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step procedure with sA-rGG and PAP was 
repeated once, to increase the number of perox- 
idase molecules/i~unoreactive site [ 11. Perox- 
idase was then revealed with 3,3 ’ -tetr~ydrochlor- 
odiaminobenzidine (0.5 m&ml, 50 mM Tris-HCl, 
pH 7.6), activated with 0.2% (v/v) Hz02 for 10 
min, giving a brown-coloured reaction product. 
The immunostained NTC sheet was dried and the 
app. M, of immunostain~ bands was measured 
with reference to a low-d& markers SDS calibra- 
tion kit of Pharmacia consisting of phosphorylase 
b (AC& 94 OOO), bovine serum ~bu~n (MX 67 OOO), 
ovalbumin @& 45000), carbonic anhydrase (M 
30000), trypsin inhibitor (M 20 IOO}, and cy- 
lact~bumin (M 14400). In several IPE experi- 
ments, cytochrome c (Mr 12700) was included as 
internal coloured standard at 0.3 mg/ml, The 
double-bridge immuno~ro~dase t~hniqu~ gave a 
distinct brown-coloured spot, when as little as 1.0 
pg standard PRL was applied directly on NTC 
hPRL a b cde f 
paper in 1 .O pl PBS (not shown), 
3. RESULTS 
By IPE of crude homogenates of human 
pituitary, anti-hGH and anti-hPL sera allowed the 
immunostaining of the same 4 protein bands: a 
predominant MI 22000 form, a band with MI 
20000, and 2 fainter bands with Mr 65 000 and 
75000 (fig. la,2k,l). 
The staining pattern obtained for hPRL by IPE 
of the same tissue homogenates was also complex. 
The 2 anti-oPRL sera and the anti-rPRL serum 
always revealed the same 4 A& 25 000, M, 29000, 
Mz 45 000 and Mr 16 000 peptides in the order of 
decreasing immunost~ning (fig. lb, 2a-h, 3). A 
purified hPRL preparation tested by IPE with the 
same 3 anti-PRL sera showed a single A& 25 000 
peptide (fig. Ic) corresponding to the M, 25 000 
band stained by silver on polyac~lamide gel. 
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Fig, 2. IPE pattern of a human pituitary homogenate corresponding to25Opg tissue wet wt (lanes a, b) and 25gg tissue 
wet wt (lanes c-n). The nitrocelluIose strips were incubated with 5 antisera: anti-rPRL (lanes a,c,d), anti-oPRL (Ba-603) 
lanes b,e,f% anti-oPRL (Mi-770) (lanes g,h), anti-hPRL (lanes i,j), anti-hPL (lanes k,l). Control strips were incubated 
with normal rabbit serum (lane m), and with PSB-NSS (lane n). The sera were diluted 1: 1000 in lanes a,b,c,e,g,i,k,m, 
and 1: 10,000 in lanes, d,f,h,g,l, The mobiljtjes and corres~ndin~ Mf ( x 10e3) of the immunoreactive forms of hPRL 
and hGH are shown, respectively, on the left and right sides of the figure by reference to a log-M, standard curve obtain- 
ed with the calibration kit (see fig. 2). In addition, cytochrome c (cyt c, M, 12700) was added to the initial homogenate 
as an internal coloured standard. 
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Fig. 3. Semi-quantitative IPE analysis of hPRL variants 
in a human pituitary homogenate, using anti-oPRL (Ba 
603) serum at a 1: 10000 dilution. Decreasing tissue wet 
weight in 10 pl aliquots were applied per lane of the 
gel:250 pg (lane a); 25 pg (lane b), 2.5 pg (lance c); and 
0.25pg (lane d). k&-Values of the immunoreactive forms 
of hPRL are indicated on the left side of the figure by 
the arrows. The presence of cytochrome c (cyt. c) added 
as an internal coloured standard, is also apparent. 
When incubated with the anti-hGH serum, the 
hPRL band was not immunostained (fig. Id). 
A semi-quantitative valuation of the immuno- 
reactivity of these four proteins bands was per- 
formed by serial dilutions (10 x dilution factor) of 
a whole pituitary homogenate (fig. 3). The M, 
25 000 peptide was apparently the most abundant, 
the M, 29000, A4, 45 000, and M, 16000 im- 
munoreactive variants being, respectively, lo-, 
loo-, and lOOO-times less abundant and/or 
immunoreactive. 
The IPE profiles of crude human pituitary 
homogenate obtained with the anti-hPRL serum 
used consisted of 6 protein bands: 4 bands cor- 
responded to those stained by the anti-oPRL and 
anti-rPRL sera, while the additional 2, revealed at 
similar antiserum dilution, comigrated with the M, 
20 000 and IV& 22 000 peptides tained with the anti- 
hGH and anti-hPL sera (fig. 2i,j). 
No staining of protein bands was obtained by 
IPE of crude human pituitary homogenates, when 
using PBS-NSS or NRS instead of the anti- 
hormone sera (fig. 2m,n). 
4. DISCUSSION 
The anti-hGH and anti-hPL sera stained four 
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protein bands by IPE of crude homogenates of the 
same pituitary, at the same antibody dilution. Two 
of them corresponded to well-characterized forms 
of hGH [4]: the predominant form of hGH (MI 
22 000) and its variant (Mr 20 000). The two other 
slow migrating immunoreactive forms (M 65 000 
and 75 000) stained by IPE at the same antibody 
dilution are likely to be hGH-related. These two 
slow forms were, like the two main forms, stained 
with the anti-hPL serum as well as with the anti- 
hGH serum. Since there is some 80% homology 
between the amino acid sequences of hGH and 
hPL [15], this observation confirms that the two 
slow migrating bands were antigenically related to 
hGH. It is, indeed, unlikely that the IPE staining 
of these slow migrating forms, obtained with anti- 
hGH and anti-hPL sera, was due to non-specific 
antibodies raised against identical protein con- 
taminants common to pituitary and placenta. 
Finally, since proteins in human pituitaries were 
separated by SDS-PAGE under reducing condi- 
tions, the M, 65 000, and 75 000 forms were not 
hGH disulfide-linked oligomers, but represented 
hGH-related monomeric variants. 
Concerning PRL, the four anti-PRL sera used 
were able to stain the same 4 protein bands in 
human pituitary homogenates. The predominant 
one (MI 25 000) corresponds to purified prolactin. 
Since the three other forms (Mr 29 000, 45 000 and 
16000) were immunostained with antisera raised 
against pituitary PRL purified from 3 animal 
species, we consider them as immunoreactive 
variants of PRL. So far, these monomeric PRL- 
related peptides were not described. Such 
heterogeneity of PRL should not be confused with 
that revealed by exclusion chromatography. By 
this procedure, unreduced pituitary PRL is found 
in high Mr fractions [16]. These forms are not 
monomeric variants. 
Here, the A4, 29 000 and M, 45 000 PRL forms 
were seen despite the reducing conditions and 
were, thus, monomeric forms. 
Despite the 26% homology between the amino 
sequences of hGH and hPRL [ 17, 181, no distinct 
immunological cross-reaction could be detected by 
IPE except with the anti-hPRL serum. The lack of 
specificity should be conceivably due to a con- 
tamination of the immunogen with hGH variants 
and/or to antibodies recognizing antigenic deter- 
minants common to hPRL and hGH variants. 
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Here IPE z&owed the demonstration of the M; 
heterogeneity of growth hormone and prolactin in 
crude homogenate of the human pituitary without 
previous purification. We demonstrated a similar 
heterogeneity of these hormones (including low i% 
variants) in the rat pituitary removed immediateIy 
after decapitation (unpublished). 
It would be of great interest to know which of 
these forms are secreted and whether they are 
biologically active and of physiopathological 
significance. 
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IPE proved to be a simple, highly sensitive 
antibody-saving technique, susceptible of extensive 
application in biomedical research. 
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